InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

Current share price for BOT : $0.009 0.001 (10%)+

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Proposed issue of securities - BOT 31 Oct 2022 10:23AM $0.063 $0.009 fallen by 85.71%
$25 A$5 million Institutional Placement and Share Purchase Plan 31 Oct 2022 10:21AM $0.063 $0.009 fallen by 85.71%
$25 Appendix 4C - Quarterly 27 Oct 2022 6:39PM $0.063 $0.009 fallen by 85.71%
$25 Trading Halt 27 Oct 2022 9:44AM $0.063 $0.009 fallen by 85.71%
$25 Botanix receives A$3.7m R&D Tax Incentive Refund 26 Oct 2022 8:56AM $0.063 $0.009 fallen by 85.71%
$25 BOT Announces Promotion and Focus on NDA Approval Readiness 21 Oct 2022 9:27AM $0.065 $0.009 fallen by 86.15%
$25 Letter to Shareholders - Annual General Meeting 21 Oct 2022 9:23AM $0.065 $0.009 fallen by 86.15%
$25 Notice of Annual General Meeting/Proxy Form 21 Oct 2022 9:21AM $0.065 $0.009 fallen by 86.15%
$25 Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea 13 Oct 2022 9:47AM $0.059 $0.009 fallen by 84.75%
$25 Trading Halt 12 Oct 2022 9:50AM $0.059 $0.009 fallen by 84.75%
$25 BOT Submits FDA New Drug Application for Sofpironium Bromide 26 Sep 2022 8:19AM $0.062 $0.009 fallen by 85.48%
$25 Appendix 4G 16 Sep 2022 5:37PM $0.067 $0.009 fallen by 86.57%
$25 Annual Report to shareholders 16 Sep 2022 5:37PM $0.067 $0.009 fallen by 86.57%
$25 Change in substantial holding 13 Sep 2022 9:31AM $0.066 $0.009 fallen by 86.36%
$25 Ceasing to be a substantial holder 13 Sep 2022 9:27AM $0.066 $0.009 fallen by 86.36%
$25 Issue of First $7.0m Tranche of A$7.5m Placement Completed 12 Sep 2022 9:49AM $0.070 $0.009 fallen by 87.05%
$25 Notification regarding unquoted securities - BOT 12 Sep 2022 9:40AM $0.070 $0.009 fallen by 87.05%
$25 Notification regarding unquoted securities - BOT 12 Sep 2022 9:39AM $0.070 $0.009 fallen by 87.05%
$25 Notification regarding unquoted securities - BOT 12 Sep 2022 9:31AM $0.070 $0.009 fallen by 87.05%
$25 Notification regarding unquoted securities - BOT 12 Sep 2022 9:24AM $0.070 $0.009 fallen by 87.05%
$25 Secondary Trading Notice 12 Sep 2022 9:20AM $0.070 $0.009 fallen by 87.05%
$25 Application for quotation of securities - BOT 12 Sep 2022 9:16AM $0.070 $0.009 fallen by 87.05%
$25 Annual General meeting 12 Sep 2022 9:13AM $0.070 $0.009 fallen by 87.05%
$25 Proposed issue of securities - BOT 2 Sep 2022 9:27AM $0.080 $0.009 fallen by 88.75%
$25 Proposed issue of securities - BOT 2 Sep 2022 9:26AM $0.080 $0.009 fallen by 88.75%

351 - 375 of 726 results

Page 15 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.